# Heartflow, Inc.: filings

HTFL · Nasdaq · CIK 1464521 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/htfl.md) · [Financials](/companies/htfl/financials.md) · [Filings](/companies/htfl/filings.md) · [Insiders](/companies/htfl/insiders.md)

## Reports and events: 18 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 76, 144 37, 3 13, 8-K 9, D 8, SCHEDULE 13G/A 7, SCHEDULE 13G 6, 10-Q 4, D/A 4, UPLOAD 4, CORRESP 3, DRS/A 3, DRSLTR 3, S-8 3, S-1/A 2, 10-K 1, 144/A 1, 424B4 1, 8-A12B 1, ARS 1, CERT 1, DEF 14A 1, DEFA14A 1, DRS 1, EFFECT 1, S-1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 16:11 ET | [10-Q](/filings/0001464521-26-000131.md) | Quarterly report, period 2026-06-30 | 0001464521-26-000131 |
| 2026-08-13 | 16:02 ET | [8-K](/filings/0001464521-26-000129.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001464521-26-000129 |
| 2026-06-18 | 16:10 ET | [8-K](/filings/0001464521-26-000081.md) | 5.07 Shareholder vote results | 0001464521-26-000081 |
| 2026-05-14 | 16:31 ET | [10-Q](/filings/0001464521-26-000071.md) | Quarterly report, period 2026-03-31 | 0001464521-26-000071 |
| 2026-05-14 | 16:03 ET | [8-K](/filings/0001464521-26-000069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001464521-26-000069 |
| 2026-04-29 | 09:00 ET | [DEF 14A](/filings/0001193125-26-189307.md) | Proxy statement, period 2026-06-16 | 0001193125-26-189307 |
| 2026-03-18 | 16:17 ET | [10-K](/filings/0001464521-26-000042.md) | Annual report, period 2025-12-31 | 0001464521-26-000042 |
| 2026-03-18 | 16:02 ET | [8-K](/filings/0001464521-26-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001464521-26-000040 |
| 2026-01-12 | 08:30 ET | [8-K](/filings/0001464521-26-000005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001464521-26-000005 |
| 2025-11-12 | 17:20 ET | [10-Q](/filings/0001464521-25-000019.md) | Quarterly report, period 2025-09-30 | 0001464521-25-000019 |
| 2025-11-12 | 16:03 ET | [8-K](/filings/0001464521-25-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001464521-25-000018 |
| 2025-09-19 | 08:31 ET | [10-Q](/filings/0001464521-25-000012.md) | Quarterly report, period 2025-06-30 | 0001464521-25-000012 |
| 2025-09-10 | 07:30 ET | [8-K](/filings/0001464521-25-000009.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001464521-25-000009 |
| 2025-08-25 | 16:03 ET | [8-K](/filings/0001464521-25-000005.md) | 1.02 Termination of a material agreement | 0001464521-25-000005 |
| 2025-08-11 | 17:08 ET | [8-K](/filings/0001628280-25-039636.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-039636 |
| 2025-08-06 | 07:42 ET | [S-1/A](/filings/0001628280-25-038091.md) | Registration statement, amended | 0001628280-25-038091 |
| 2025-08-01 | 07:32 ET | [S-1/A](/filings/0001628280-25-037144.md) | Registration statement, amended | 0001628280-25-037144 |
| 2025-07-17 | 17:09 ET | [S-1](/filings/0001628280-25-035242.md) | Registration statement | 0001628280-25-035242 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 18:01 ET. No prices; not investment advice.